Description

📌 What is Survodutide?

A dual GLP-1/glucagon receptor agonist for metabolic research.

• 💡 Main Research Areas (Experimental)
• 🔥 Weight Loss: Enhanced fat oxidation
• 🩸 Glycemic Control: Improved insulin dynamics
• ❤ Liver Health: Potential MASH/MASLD benefits
• 💪 Energy Expenditure: Glucagon-driven effects

⚙ How It Works

Dual agonism combines appetite suppression with increased energy use.

📈 Benefits at a Glance

✅ Dual incretin + glucagon action
✅ Strong metabolic and liver research
✅ Fat loss with energy boost
✅ Promising for obesity complications

⚠ Note: For research use only. ≥99% purity, lab-tested in Canada.